ストックスクリーナーアプリを入手
7.68
2.81%
0.21
Oric Pharmaceuticals Inc (ORIC) 最新ニュース
HC Wainwright Reaffirms "Buy" Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Wedbush Expects Reduced Earnings for ORIC Pharmaceuticals - MarketBeat
Wedbush Predicts Weaker Earnings for ORIC Pharmaceuticals - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up on Earnings Beat - MarketBeat
ORIC Pharmaceuticals Inc (ORIC) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register
ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.6%Should You Sell? - MarketBeat
ORIC Pharmaceuticals (NASDAQ:ORIC) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
ORIC Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Oric Pharmaceuticals, Inc. SEC 10-K Report - TradingView
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates - GlobeNewswire
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and ... - The Bakersfield Californian
ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 6.4%Should You Sell? - MarketBeat
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap UpWhat's Next? - MarketBeat
ORIC Pharmaceuticals' (ORIC) "Buy" Rating Reiterated at Guggenheim - MarketBeat
ORIC Pharmaceuticals stock target holds at $21 by H.C. Wainwright - MSN
Oric recent weakness a buying opportunity, says JPMorgan - MSN
ORIC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Jones Trading maintains Buy on ORIC, $17 target on positive data - MSN
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up – What’s Next? - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Given “Buy” Rating at Guggenheim - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 14.7%Time to Buy? - MarketBeat
ORIC Pharmaceuticals (NASDAQ:ORIC) Given New $21.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Oric Pharmaceuticals: Promising Trials and Strong Financials Justify Buy Rating - TipRanks
ORIC Pharmaceuticals shares surge on potential data leak - MSN
Optimistic Buy Rating for Oric Pharmaceuticals Driven by Promising Data and Favorable Risk/Reward Profile - TipRanks
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.29 Consensus Price Target from Analysts - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for ORIC Pharmaceuticals (NASDAQ:ORIC) Stock - Armenian Reporter
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 15.6%Here's Why - MarketBeat
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ORIC Pharma's Latest Talent Investment: Strategic Equity Awards Unveiled - StockTitan
There is no doubt that ORIC Pharmaceuticals Inc (ORIC) ticks all the boxes. - SETE News
ORIC Pharmaceuticals Inc (ORIC) may enjoy gains as insiders got busy in the recent days - Knox Daily
Daily Market Movement: ORIC Pharmaceuticals Inc (ORIC) Sees a -2.59 Decrease, Closing at 10.15 - The Dwinnex
ORIC Pharmaceuticals Inc (ORIC)’s stock chart: A technical perspective - US Post News
Citi maintains ORIC stock Buy rating, $13 target ahead of PFE data - MSN
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 15.6% – Still a Buy? - Armenian Reporter
ORIC Pharmaceuticals: Too Early To Commit, Despite Some Good Early Data - Seeking Alpha
SG Americas Securities LLC Sells 3,256 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
JPMorgan Chase & Co. Increases Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
ORIC Pharmaceuticals to Present at Three Major Healthcare Investor Conferences - StockTitan
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.6%Should You Buy? - MarketBeat
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):